Key result
Ebselen reduces cortical oxidative stress and alleviates neuronal damage in stroke-prone hypertensive rats.
RCT (n=22)
Randomized
Answers are grounded in this paper and cite their sources.
An increase in reactive oxygen species has been shown to play a role in perpetuating hypertension and cerebral injury in stroke-prone spontaneously hypertensive rats (SHRsp). Lipid peroxidation in the cerebral cortex is much more intense in SHRsp after establishment of severe hypertension as compared to that in normotensive Wistar-Kyoto rats (WKY). Cortical neurons from SHRsp are more vulnerable to hypoxia and hyponutritional conditions. We sought to investigate whether long-term administration of seleno-glutathione peroxidase mimic ebselen (PZ51) would have a protective effect on cortical neurons in SHRsp, and, if so, the possible mechanisms of this effect. Twenty-two 8-week-old SHRsp were randomized into a PZ51 group and control group. Age-matched WKY were used as normal controls. We examined the levels of malonaldehyde (MDA) and nitric oxide (NO) in the cerebral cortex (CC) homogenate, detected the three isoforms of nitric oxide synthase (NOS) by Western blotting, and examined cortical neurons by transmission electron microscopy. The results showed that PZ51 treatment significantly decreased both MDA and NO in the CC, inhibited inducible nitric oxide synthase (iNOS) protein expression, and alleviated the damage to cortical neurons compared to the findings for the control group. In conclusion, the present study showed that PZ51 administration suppressed lipid peroxidation and inhibited iNOS protein expression in CC homogenate, and it was suggested that these mechanisms may play a role in the protective effects of PZ51 on cortical neurons of SHRsp.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2005) conducted an RCT in Hypertension and cerebral injury in stroke-prone spontaneously hypertensive rats (SHRsp) (n=22). Ebselen (PZ51) vs. Control group (untreated SHRsp and age-matched WKY normal controls) was evaluated on Levels of malonaldehyde (MDA) and nitric oxide (NO), nitric oxide synthase (NOS) isoform expression, and cortical neuron ultrastructure in the cerebral cortex. Ebselen (PZ51) treatment in 22 SHRsp rats significantly decreased cerebral cortex malonaldehyde and nitric oxide, inhibited iNOS expression, and alleviated cortical neuron damage vs controls.
Synapse has enriched 10 related papers. Consider them for comparative context: